GlobeNewswire Inc.··Oculis Holding AgOculis Eyes DME Market Opportunity as Study Reveals 60% Patient Non-Treatment Rate
Oculis-backed research reveals significant unmet needs in diabetic macular edema treatment, with 60% of patients remaining untreated due to invasive therapies.
OCSOCSAWdiabetic macular edemanon-invasive treatment